PLIANT THERAPEUTICS INC's ticker is PLRX and the CUSIP is 729139105. A total of 146 filers reported holding PLIANT THERAPEUTICS INC in Q2 2024. The put-call ratio across all filers is 0.31 and the average weighting 0.4%.
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Mass General Brigham, Inc | 288,690 | $3,103,418 | 15.11% |
TRV GP IV, LLC | 2,132,867 | $22,928,320 | 11.34% |
Blue Owl Capital Holdings LP | 3,004,199 | $32,295,139 | 8.98% |
GREAT POINT PARTNERS LLC | 2,636,864 | $28,346,288 | 5.43% |
First Light Asset Management, LLC | 3,401,213 | $36,563,040 | 3.20% |
Redmile Group, LLC | 3,209,591 | $34,503,103 | 2.09% |
Deep Track Capital, LP | 5,972,257 | $64,201,763 | 1.92% |
Fernwood Investment Management, LLC | 496,286 | $5,335,075 | 1.66% |
Checkpoint Capital L.P. | 232,200 | $2,496,150 | 1.50% |
Exome Asset Management LLC | 124,000 | $1,333,000 | 1.16% |
Casdin Capital, LLC | 1,000,000 | $10,750,000 | 0.82% |
Bond & Devick Financial Network, Inc. | 100,160 | $1,076,720 | 0.58% |
HighMark Wealth Management LLC | 67,500 | $725,625 | 0.44% |
Granahan Investment Management | 982,049 | $10,557,027 | 0.42% |
ACUTA CAPITAL PARTNERS, LLC | 46,200 | $496,650 | 0.42% |
SPHERA FUNDS MANAGEMENT LTD. | 258,554 | $2,779,456 | 0.38% |
Laurion Capital Management LP | 2,498,920 | $26,863,390 | 0.32% |
HARBOURVEST PARTNERS LLC | 49,434 | $531,416 | 0.28% |
RA Capital Management | 1,281,000 | $13,770,750 | 0.18% |
Polar Capital Holdings Plc | 2,015,000 | $21,661,250 | 0.13% |
External links
This page lists PLIANT THERAPEUTICS INC's shareholders in Q2 2024. To view PLIANT THERAPEUTICS INC's shareholder history, click here.